Boston Financial Mangement LLC lowered its stake in Colgate-Palmolive Company (NYSE:CL) by 6.9% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 61,382 shares of the company’s stock after selling 4,575 shares during the period. Boston Financial Mangement LLC’s holdings in Colgate-Palmolive were worth $4,550,000 as of its most recent SEC filing.

Several other large investors also recently made changes to their positions in CL. Waldron LP acquired a new stake in shares of Colgate-Palmolive in the first quarter worth about $238,000. First Citizens Bank & Trust Co. acquired a new stake in shares of Colgate-Palmolive in the first quarter worth about $563,000. Chickasaw Capital Management LLC lifted its position in shares of Colgate-Palmolive by 218.3% in the first quarter. Chickasaw Capital Management LLC now owns 16,920 shares of the company’s stock worth $1,238,000 after buying an additional 11,605 shares during the last quarter. Glen Harbor Capital Management LLC lifted its position in shares of Colgate-Palmolive by 3.6% in the first quarter. Glen Harbor Capital Management LLC now owns 212,268 shares of the company’s stock worth $15,536,000 after buying an additional 7,280 shares during the last quarter. Finally, Mycio Wealth Partners LLC acquired a new stake in shares of Colgate-Palmolive in the first quarter worth about $216,000. 73.10% of the stock is owned by institutional investors.

Colgate-Palmolive Company (NYSE CL) opened at 72.39 on Tuesday. The firm has a market cap of $63.76 billion, a PE ratio of 26.90 and a beta of 0.80. The company’s 50 day moving average price is $71.57 and its 200 day moving average price is $73.27. Colgate-Palmolive Company has a 52-week low of $63.43 and a 52-week high of $77.27.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, July 21st. The company reported $0.72 EPS for the quarter, hitting analysts’ consensus estimates of $0.72. Colgate-Palmolive had a return on equity of 3,121.95% and a net margin of 15.83%. The business had revenue of $3.83 billion during the quarter, compared to analysts’ expectations of $3.89 billion. During the same quarter last year, the company posted $0.70 earnings per share. Colgate-Palmolive’s quarterly revenue was down .5% on a year-over-year basis. Analysts predict that Colgate-Palmolive Company will post $2.89 earnings per share for the current fiscal year.

In other Colgate-Palmolive news, insider Patricia Verduin sold 3,833 shares of the firm’s stock in a transaction that occurred on Tuesday, August 15th. The shares were sold at an average price of $71.45, for a total transaction of $273,867.85. Following the completion of the sale, the insider now directly owns 53,173 shares in the company, valued at $3,799,210.85. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, COO Justin Skala sold 74,374 shares of the firm’s stock in a transaction that occurred on Thursday, July 27th. The stock was sold at an average price of $72.51, for a total transaction of $5,392,858.74. Following the sale, the chief operating officer now owns 97,177 shares of the company’s stock, valued at $7,046,304.27. The disclosure for this sale can be found here. Insiders have sold 217,969 shares of company stock valued at $15,693,933 in the last quarter. 1.02% of the stock is currently owned by corporate insiders.

COPYRIGHT VIOLATION WARNING: This article was published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this article on another domain, it was stolen and republished in violation of U.S. and international trademark & copyright legislation. The correct version of this article can be accessed at https://www.thecerbatgem.com/2017/09/19/boston-financial-mangement-llc-has-4-55-million-holdings-in-colgate-palmolive-company-cl.html.

CL has been the subject of a number of analyst reports. Zacks Investment Research raised Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $83.00 price target for the company in a research report on Tuesday, July 4th. Jefferies Group LLC boosted their price target on Colgate-Palmolive from $76.00 to $77.00 and gave the stock a “hold” rating in a research report on Thursday, July 6th. Bank of America Corporation boosted their price target on Colgate-Palmolive from $78.00 to $80.00 and gave the stock a “buy” rating in a research report on Wednesday, May 31st. BidaskClub cut Colgate-Palmolive from a “sell” rating to a “strong sell” rating in a research report on Wednesday, July 12th. Finally, Wells Fargo & Company reaffirmed a “market perform” rating on shares of Colgate-Palmolive in a research report on Monday, July 24th. Two investment analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and two have issued a buy rating to the stock. The company has an average rating of “Hold” and a consensus target price of $75.83.

Colgate-Palmolive Profile

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Stock Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related stocks with our FREE daily email newsletter.